Hypomagnesemia in Chronic Kidney Disease Stage 5
Journal Title: Нирки - Year 2016, Vol 1, Issue 15
Abstract
The article describes the clinical case of correction of hypomagnesemia in a patient 49 years with chronic kidney disease stage 5 with application magnesium orotate.
Authors and Affiliations
Z. V. Babenko
Keywords
Related Articles
- EP ID EP208433
- DOI -
- Views 92
- Downloads 0
Use of Pharmacogenotyping and Dosage of Certain Drugs in the Urology and Nephrology
The article is devoted to the use of methods of pharmacogenetically and aspects of dosing of some drugs used in Nephrology and Urology. Described angiotensin converting enzyme inhibitors (aceis), beta-adrenoblockers (BAB...
Kidney Transplantation on Children
.
Intravenous Iron Drugs Usage in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease
The article reviews the current recommendations on treating anemia in chronic kidney disease. It is emphasized on the priority appointment of iron preparations. The comparative characteristic of iron supplementation effi...
European Association of Urology, 2017 Paediatric Urology Guidelines. Urological infections. Summary of changes
.
Candesartan in nephrological practice
First-line drugs in the treatment of hypertension in patients with chronic kidney disease is an angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. The topic of the article is devoted to compar...